In the present narrative review we aim to explore the role of VEGF signaling in oral cancer and destructive periodontal inflammatory diseases, with emphasis in its translational applications as potential biomarkers and therapeutic targets. The gene discussed is VEGFA; the disease is lip and oral cavity carcinoma.